KAPIDEX (dexlansoprazole delayed release capsules)  is available as capsules in 30 mg and 60 mg strengths for adult use.   Directions for use in each indication are summarized in Table 1.
Table 1: KAPIDEX (dexlansoprazole delayed release capsules)  Dosing Recommendations 
No adjustment for KAPIDEX (dexlansoprazole delayed release capsules)  is necessary for patients with mild hepatic impairment    (Child-Pugh Class A). Consider a maximum daily dose of 30 mg for patients with    moderate hepatic impairment (Child-Pugh Class B). No studies have been conducted    in patients with severe hepatic impairment (Child-Pugh Class C) [see Use    in Specific Populations and CLINICAL PHARMACOLOGY].
No dosage adjustment is necessary for elderly patients or for patients with   renal impairment [see CLINICAL PHARMACOLOGY].
KAPIDEX (dexlansoprazole delayed release capsules)  can be taken without regard to food. KAPIDEX (dexlansoprazole delayed release capsules)  should be swallowed whole.
